NIH F31 Grants — Individual Predoctoral Fellowship

Recent F31 awards from NIH RePORTER

Examples of funded F31 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on September 5, 2026.

Example F31 projects from the sample

• AAV gene therapy to restore fertility in mammalian Sertoli cell dysfunction models

  6F31HD114406-04
  Georgia Rae Atkins · UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA · $50,114 · awarded Aug 27, 2026 · NIH

  ABSTRACT: Infertility impacts 48 million couples worldwide and 50% of cases are due to a male factor. Non-obstructive azoospermia (NOA) is the absence of sperm due to spermatogenic failure. Some cases are due to known conditions (Klinefelter’s Syndrome, Y chromosome microdeletions, and hypogonadism) but many cases are idiopathic (unexplained). Recent…

• Defining Immune Dysfunction in Chronic Hepacivirus Infection at Single Cell Resolution

  5F31AI186462-03
  Tesia Bobrowski · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY · $50,114 · awarded Aug 27, 2026 · NIH

  PROJECT SUMMARY/ABSTRACT Hepatitis C virus (HCV) is a hepacivirus that chronically infects an estimated 58 million people worldwide and can result in end-stage liver disease. It has been well established that ineffectual T cell responses contribute to the establishment and maintenance of chronic HCV infection. Namely, T cell exhaustion, wherein T cells lose…

• Formative Research on How Faith Communities can Promote Lung Cancer Screening

  5F31CA294990-02
  Shacoria Anderson · EMORY UNIVERSITY, GA · $50,114 · awarded Aug 21, 2026 · NIH

  PROJECT SUMMARY/ABSTRACT Lung cancer is the leading cause of cancer-related deaths in the United States and worldwide, accounting for 20% of all cancer deaths and despite advancements in early detection, lung cancer screening rates remain suboptimal in the U.S. (18%). Faith-based settings have proven to be an effective implementation setting for promoting…

• Characterizing EZH1 Gain of function mutations to understand neurodevelopmental disease and inform EZH1-inhibitor innovation

  5F31NS145736-02
  James Bauer · UNIVERSITY OF PENNSYLVANIA, PA · $50,114 · awarded Aug 21, 2026 · NIH

  PROJECT SUMMARY/ABSTRACT: Neurodevelopmental disorders (NDDs) represent a diverse array of conditions characterized by abnormal brain development and function which cause motor, cognitive, and communicative deficits that greatly impact a patient’s quality of life. However, many underlying disease mechanisms are still unknown, resulting in a dearth of…

• Integrating Structural and Biochemical Approaches to Define Lipid-Dependent TAM Receptor Activation

  1F31AI203078-01
  Maria Arango · UNIV OF NORTH CAROLINA CHAPEL HILL, NC · $41,340 · awarded Aug 13, 2026 · NIH

  ABSTRACT TAM receptors (Tyro3, Axl, and Mer) are receptor tyrosine kinases that couple apoptotic cell clearance to the regulation of inflammation and immune homeostasis, and their dysregulation contributes to autoimmune disease, neurodegeneration, impaired pathogen clearance, infertility, and cancer. Tyro3 is the least understood TAM receptor, yet has been…

• Delineating Barriers to the Effectiveness of Wolbachia-Based Interventions for Arboviral Risk Reduction

  1F31AI203216-01
  Paloma Carcamo · YALE UNIVERSITY, CT · $50,114 · awarded Aug 11, 2026 · NIH

  PROJECT SUMMARY/ABSTRACT Dengue and other Aedes-borne diseases pose a significant and increasing public health challenge in southern U.S. states and territories, where Aedes aegypti is established and local transmission has already occurred. At present, there is no effective prevention of Aedes-borne diseases in the U.S. Wolbachia-based interventions are a…

• Quantitative magnetic resonance imaging for non-invasive breast cancer therapy using physics-informed neural networks.

  5F31CA288055-03
  Samuel Adams · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH, UT · $41,997 · awarded Aug 10, 2026 · NIH

  Project Summary My overarching goal is to become a biomedical engineer capable of advancing minimally invasive procedures through medical imaging and machine learning. To achieve this, I aim to develop a broad understanding of diagnostic and interventional radiology and robust technical skills in acquiring, reconstructing, and applying machine learning…

• The role of sex chromosomes in neonatal hyperoxic lung injury

  5F31HL179994-02
  Rose Albert · UNIVERSITY OF PENNSYLVANIA, PA · $50,114 · awarded Aug 6, 2026 · NIH

  PROJECT SUMMARY Bronchopulmonary dysplasia (BPD) is the most common complication affecting preterm neonates and is defined by supplemental oxygen dependence at 36 weeks postmenstrual age. Advances in neonatal care have improved overall survival of preterm neonates though BPD prevalence continues to increase. BPD develops after early-life lung injury caused…

• Implementation determinants and community-based prevention for cardiometabolic disease in Mozambique: a pilot study

  5F31HL175834-03
  Amanda Brumwell · UNIVERSITY OF WASHINGTON, WA · $51,425 · awarded Aug 6, 2026 · NIH

  SUMMARY/ABSTRACT The burden of noncommunicable diseases (NCDs), including cardiometabolic disease, is increasing globally, particularly in low- and middle-income countries (LMICs). NCDs are responsible for an estimated 35% of all deaths in sub-Saharan Africa, and in Mozambique nearly 60% of all DALYs are attributable to NCDs and injury. The prevalence of…

• Pathways of Personality Disorder: Combining Multiple Methods of Repeated Assessment Across Development and in Daily Life

  5F31MH140528-02
  Kennedy Balzen · UNIVERSITY OF HOUSTON, TX · $38,127 · awarded Aug 5, 2026 · NIH

  PROJECT SUMMARY Personality disorder (PD) is a severely debilitating psychiatric illness. PD is associated with high healthcare costs, high rates of self-harm and suicidality, and greater disability than major depressive disorder. PD demonstrates a comparable or higher prevalence to depressive and anxiety disorders, and a comparable prevalence to physical…

• Targeting fibrosis to change cancer outcomes

  5F31CA284547-05
  Joey Breckenridge · UNIVERSITY OF CINCINNATI, OH · $50,100 · awarded Aug 5, 2026 · NIH

  PROJECT SUMMARY Scleroderma (SSc) patients have more than a 300% increased risk of lung cancer, or Cancerous Scleroderma (CSc). SSc is a chronic autoimmune connective tissue disease of unknown etiology, and has the highest morbidity of all rheumatologic diseases. Moreover, aging is a key risk factor in SSc patients for pathological airway remodeling or…

• Investigating the Molecular and Cellular Basis of RNA Exosome-linked Pontocerebellar Hypoplasia Type1b in Human 3D Brain Organoids

  5F31NS139645-02
  Nina Barr · UNIVERSITY OF SOUTHERN CALIFORNIA, CA · $46,168 · awarded Aug 4, 2026 · NIH

  PROJECT SUMMARY The diversity of neuronal cell types within the mammalian brain is derived from neural stem cells that sequentially express specific transcriptional programs. Control of gene expression programs is critically important for proper neural stem cell differentiation and subtype specification, which consists of many regulatory processes,…

Compare nearby NIH grant mechanisms

Searchers often land on F31 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.